Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Idiopathic Parkinson’s Disease handout Dr Sabrina Akhtar Definition: Idiopathic Parkinson’s disease (IPD) is a degenerative, progressive disease affecting the basal ganglia. It is classified as a movement disorder under the akinetic-rigid syndromes. Classical features of these syndromes include slowed movement and increased tone. Parkinsonism is the clinical definition of several underlying pathologies that can cause Parkinson’s-like symptoms such as: - Resting tremor Rigidity Bradykinesia Postural instability These are also the main symptoms of IPD. IPD is the most common form of parkinsonism. Aetiology: - Unknown aetiology. Several postulated theories: cigarette smoking, MPTP link (by-product of illicit stimulant drug production) and genetic factors. Pathology: IPD arises as a result of: i) Reduced dopaminergic output from the substantia nigra (due to depletion of pigmented dopaminergic neurons). ii) Development of inclusion bodies (Lewy bodies in nigral cells). iii) Degeneration in other basal ganglia nuclei. Depletion of pigmented dopaminergic neurons in SN Reduced dopaminergic output from SN Inclusion bodies (Lewy bodies) develop in nigral cells Degeneration in other basal ganglia nuclei Neurons in subthalamic nucleus become more active than usual in inhibiting activation of the cortex Bradykinesia Clinical features: Resting tremor- present at rest and when distracted. Diminished on action. Rigidity- cogwheel rigidity (mainly upper limbs) and lead pipe rigidity (mainly lower limbs). Bradykinesia- difficulty initiating movement/ poor rapid, fine movements (especially of fingers)/ facial immobility/reduced spontaneous blinking (serpentine stare). Postural instability- loss of reflexes to maintain upright posture. May develop retropulsion. Gait- shuffling + festinating. Speech- monotone/soft/rapid/indistinct. Cognitive- cognitive impairment (1/3 of patients)/ depression. GI- Constipation/heartburn/dribbling/ dysphagia/weight loss. Others- micrographia/greasy skin. Investigations: o Clinical diagnosis. o <50 years: Test for Wilson’s disease. o CT head scan if: Pyramidal/cerebellar/autonomic involvement. Diagnosis is in doubt. Differential diagnoses: Parkinson-plus syndromes are a group of neurodegenerative disorders that have features in addition to typical IPD symptoms (i.e. resting tremor, bradykinesia, rigidity, postural instability). It is important to distinguish these from IPD as typically these syndromes have very little response to conventional therapy for IPD (i.e. dopamine replacement therapy), especially vascular parkinsonism. Management: Multi-disciplinary team management. Medical treatment is delayed until clinically necessary because of unwanted delayed effects with Levodopa therapy which include worsening of tremor and bradykinesia and the ‘on-off phenomenon’. Management Medical Surgical Levodopa + peripheral decarboxylase inhibitor. Others: -Dopamine receptor agonists (Bromocriptine/Cabergoline). -Amantadine. -Rivastigmine (cognitive changes). -Antioxidant compounds (Vitamins C & E- possible neuroprotective agents). Stereotactic thalamotomy. Multi-disciplinary Physiotherapy Reduce rigidity & correct abnormal posture. Speech therapy Dysarthria/dysphonia. Neuropsychiatric SSRI’s for depression.